Dr.ย Dae Hoย Lee
MD, MS, PhD
Professor, Medical Oncology โ Lung Cancer & Personalised Cancer Medicine
corporate_fareAsan Medical Center, Seoul, South Korea
Dae Ho Lee
MD, MS, PhD
Prof. Dae Ho Lee is a senior medical oncologist and Professor at Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. His officially verified specialties include lung cancer, thymus tumour, skin cancer, and malignant melanoma, with a particular focus on precision oncology and biomarker-guided systemic treatment.
Prof. Lee has practised medical oncology for over two decades, beginning his career at the National Cancer Center Hospital, Korea, before joining Asan Medical Center, where he progressed from Instructor to Professor from 2006 onward. He holds appointments across the AMC Cancer Institute, the Centre for Personalised Cancer Medicine, the Lung Cancer Center, and the Skin Cancer Center. His research contributions span non-small cell lung cancer outcomes, EGFR- and ALK-positive lung cancer, next-generation sequencing, targeted therapy, immunotherapy, and KRAS-mutated lung cancer, with co-authorship on large-scale South Korean NSCLC studies published in peer-reviewed journals including JAMA Network Open. His Korean Medical License number is 53562 as documented in publicly available conference CV records.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Prof. Lee at Asan Medical Center, subject to hospital availability and case acceptance.
Why Consider Prof. Dae Ho Lee?
Prof. Lee combines two decades of clinical oncology practice with an active research career in lung cancer, precision medicine, and advanced systemic therapies at one of South Korea's leading tertiary cancer centres.
Areas of Specialisation
Prof. Lee's practice covers lung cancer, thymic tumours, skin cancer, melanoma, and related precision oncology approaches.
Prof. Dae Ho Lee's clinical specialties are officially listed by Asan Medical Center as lung cancer, thymus tumour, skin cancer, and malignant melanoma. His academic work reflects deep experience in molecular oncology, targeted therapy, and immunotherapy for thoracic and skin malignancies.
Lung Cancer & Thoracic Oncology
Systemic treatment for non-small cell and small-cell lung cancer, with a focus on molecularly guided therapy and personalised treatment planning.
- arrow_rightEGFR-mutated NSCLC โ targeted therapy selection and sequencing
- arrow_rightALK-positive NSCLC โ ALK inhibitor-based treatment planning
- arrow_rightKRAS-mutated NSCLC โ emerging targeted approaches
- arrow_rightBiomarker testing and next-generation sequencing to guide treatment
- arrow_rightCheckpoint inhibitor therapy for eligible NSCLC patients
- arrow_rightEarly-phase clinical trial participation in cancer immunotherapy
- arrow_rightCombined systemic approaches for advanced lung cancer
- arrow_rightSystemic treatment planning for thymus tumours and thymoma
- arrow_rightMultidisciplinary management in collaboration with thoracic surgery and radiation oncology
Skin Cancer & Malignant Melanoma
Medical oncology management of advanced skin cancers, including melanoma, with access to modern systemic and immunotherapy approaches.
- arrow_rightSystemic treatment for advanced and metastatic melanoma
- arrow_rightImmunotherapy and targeted therapy where applicable
- arrow_rightOncology management of non-melanoma and other skin malignancies
- arrow_rightMultidisciplinary coordination with dermatology and oncology teams
Procedures Performed
Clinical services and systemic treatment approaches in medical oncology
Prof. Lee provides medical oncology consultation, systemic cancer treatment, biomarker-guided therapy planning, and second opinion services for patients with lung cancer, thymic malignancies, melanoma, and related cancers.
Medical Oncology Consultation
Medical OncologyComprehensive oncology evaluation, diagnosis review, and personalised treatment planning for lung cancer and related solid tumours.
Targeted Therapy
Targeted TherapyMolecularly guided treatment selection for patients with EGFR, ALK, KRAS, or other actionable alterations identified through biomarker testing.
Immunotherapy
Medical OncologyCheckpoint inhibitor-based treatment and combination systemic approaches for eligible lung cancer and melanoma patients.
Second Opinion
Second OpinionIndependent case review for patients with lung cancer, thymic malignancies, melanoma, or related diagnoses, supported by Asan Medical Center's international patient services.
Multidisciplinary Cancer Care
MultidisciplinaryCollaborative oncology planning within Asan Medical Center's specialised lung cancer and cancer institute teams.
Research & Publications
Peer-reviewed contributions in lung cancer, precision oncology, and immunotherapy
Prof. Dae Ho Lee has an extensive peer-reviewed publication record in lung cancer, targeted therapy, immunotherapy, and real-world oncology outcomes. Academic databases list him as an author of a substantial body of research in these fields.
Academic databases list Prof. Lee as an author of an extensive body of peer-reviewed work in lung cancer and oncology. A detailed publication list is available through PubMed and Google Scholar.
Education & Training
Prof. Lee completed his undergraduate, postgraduate, and doctoral medical training at Seoul National University, followed by residency and fellowship training at Seoul National University Hospital and the National Cancer Center Hospital, Korea.
Clinical Experience
Prof. Lee began his medical oncology career at the National Cancer Center Hospital, Korea, before joining Asan Medical Center in 2006, where he has progressed through academic ranks to his current role as Professor.
Languages & International
Prof. Dae Ho Lee consults in Korean. Asan Medical Center's International Healthcare Center provides professional multilingual interpreter support for international patients.
Asan Medical Center's International Healthcare Center and CancerFax can coordinate professional medical interpreter support for overseas patients in multiple languages.
CancerFax can coordinate medical interpreter support and patient-navigation assistance when required.
How CancerFax Helps You Access Dr. Dae Ho Lee
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Dae Ho Lee's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Dae Ho Lee's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Dae Ho Lee before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Dae Ho Lee's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Dae Ho Lee's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Dae Ho Lee's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Dae Ho Lee
Prof. Dae Ho Lee is a medical oncologist specialising in lung cancer, with additional verified clinical expertise in thymus tumours, skin cancer, and malignant melanoma. His official Asan Medical Center profile places him within the Lung Cancer Center and the Centre for Personalised Cancer Medicine.
Prof. Dae Ho Lee is based at Asan Medical Center, Seoul, South Korea, and holds an academic appointment at the University of Ulsan College of Medicine. He is affiliated with the AMC Cancer Institute, the Lung Cancer Center, the Centre for Personalised Cancer Medicine, and the Skin Cancer Center.
Yes. Prof. Lee's clinical and research profile is strongly associated with non-small cell lung cancer, including EGFR-mutated, ALK-positive, and KRAS-mutated NSCLC. He has co-authored large-scale real-world outcome studies in NSCLC and research on next-generation sequencing for targeted gene identification in lung adenocarcinoma.
Yes. Prof. Lee's academic work includes research on EGFR and ALK targeted therapy, next-generation sequencing for actionable molecular alterations, and cancer immunotherapy including early-phase clinical trial involvement. His practice is within Asan Medical Center's Centre for Personalised Cancer Medicine, which focuses on biomarker-guided cancer treatment.
International patients can approach Asan Medical Center through its International Healthcare Center, which provides appointment coordination, multilingual interpreter support, second opinion facilitation, and billing and administrative assistance for overseas patients. CancerFax can help organise medical records, prepare a structured case summary, and coordinate the next steps with the hospital, subject to availability and case acceptance.
A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging, treatment history, molecular test results, and relevant clinical records. The CancerFax team will prepare and submit the case to Asan Medical Center. The final consultation format and timeline depend on the doctor's and hospital's availability.
Connect with Dae Ho Lee Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.